Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Veronique Trognon in Pediatric Medicine
Introduction
Veronique Trognon, an accomplished inventor based in La Turballe, France, has made significant strides in pediatric medicine through her innovative work. With a patent to her name, she has contributed to the advancement of healthcare solutions tailored specifically for children. Her expertise and dedication have positioned her as a key figure in the pharmaceutical industry.
Latest Patents
Trognon is credited with a groundbreaking patent that focuses on a pediatric formulation of gatifloxacin. This invention addresses a critical need in pediatric care by providing a quinolone antibacterial that is adequately taste-masked for ease of administration. The patent describes a crystalline co-precipitate of gatifloxacin combined with stearic acid and/or palmitic acid in a narrow weight ratio. This combination effectively masks the bitter taste, allowing for a more palatable experience for children undergoing treatment. The formulation ensures that gatifloxacin remains readily available for absorption from the stomach throughout the treatment cycle, typically lasting fourteen days.
Career Highlights
Trognon’s work is anchored in her role at Bristol-Myers Squibb Company, where she collaborates with a talented team to develop innovative pharmaceutical solutions. Her patent not only showcases her creativity but also her commitment to improving the delivery of medications to young patients. Throughout her career, she has remained focused on enhancing the efficacy and safety of pediatric therapies.
Collaborations
In her endeavors, Trognon has worked alongside esteemed colleagues such as Krishnaswamy Srinivas Raghavan and Sunanda A. Ranadive. Their collaborative efforts have contributed to the research and development of several pharmaceutical innovations, emphasizing the importance of teamwork in achieving groundbreaking medical solutions.
Conclusion
Veronique Trognon exemplifies the spirit of innovation within the pharmaceutical industry. Her pioneering work on the pediatric formulation of gatifloxacin not only showcases her inventiveness but also highlights her dedication to enhancing healthcare for children. As she continues her work at Bristol-Myers Squibb Company, Trognon remains a valuable asset to the field of pediatric medicine, inspiring future generations of inventors and healthcare professionals.